Volume 3, Issue 37, 10/04/2011
Should patients who develop hyperuricemia while receiving hydrochlorothiazide (HCTZ) be started on allopurinol?
The thiazide diuretic, hydrochlorothiazide (HCTZ) remains one of the most widely prescribed and cost-effective antihypertensives available on the market. This in part due to the numerous clinical trials and practice guidelines that support the use of thiazide diuretics as first line or add-on therapy for hypertension in a broad range of patients.1,2 Furthermore, HCTZ is overall well tolerated and contraindications or warnings against its use are few.

Copyright 2012 Pharmacology Weekly, Inc. All Rights Reserved. |
